Figure 4

(a) Box plot demonstrating the distribution of miR-205 expression in nevi, primary, and metastatic melanoma specimens. (b) Kaplan–Meier survival analysis of miR-205 expression on the discovery cohort (P-value calculated by the log-rank test). (a) Kaplan–Meier survival analysis of miR-205 expression on the Validation Cohort using the same cutoff score between high and low expression as the Discovery Cohort.